Last reviewed · How we verify
NCT06742268
Extension Study on Safety and Rebound Effect of SAT-001 for Myopia in Children
trial testing Single vision spectacles in Myopia in 40 participants. Currently enrolling.
30 October 2025
Quick facts
| Lead sponsor | S-Alpha Therapeutics, Inc. |
|---|---|
| Status | Recruiting now |
| Study type | OBSERVATIONAL |
| Enrollment | 40 |
| Start date | 16 December 2024 |
| Primary completion | 30 October 2025 |
| Estimated completion | 30 July 2026 |
| Sites | 5 locations across South Korea |
Drugs / interventions tested
- Single vision spectacles
Conditions studied
- Myopia — all drugs for Myopia →
Sponsor
S-Alpha Therapeutics, Inc.
Who can join
Adults 5 to 8, any sex, with Myopia. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The objective of this clinical trial is to collect data on the rebound effect and long-term safety of SAT-001, a Software as a Medical Device (SaMD) under development for the inhibition and treatment of myopia progression in pediatric patients.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06742268
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Single vision spectacles
Trials testing the same drug.
- NCT06821074 — Defocus-Enhanced vs. Single Vision Spectacles in Myopia Control Visual Function Training · NA · recruiting
- NCT06344572 — Pivotal Study of SAT-001 in Treatment of Pediatric Patient With Myopia · NA · recruiting
- NCT05756959 — Myopia Control Combined PBM With Myopic Defocus Lens in Children · NA · recruiting
Other recruiting trials for Myopia
Currently open trials in the same condition.
- NCT07284966 — Comfort and Vision With TOTAL30 Multifocal Lenses · recruiting
- NCT07078799 — Wavefront-guided LASIK Surgery Compared to Ray Tracing-Guided LASIK Surgery · NA · recruiting
- NCT07585877 — Effect of Branched-Chain Amino Acid Supplementation on Myopia Progression · NA · active not recruiting
- NCT07354945 — An Evaluation of Myopia Control Lenses on Wearing Experience in Myopic Children · NA · recruiting
- NCT07229365 — Children's Viewing Behavior · NA · recruiting
Other S-Alpha Therapeutics, Inc. trials
Trials by the same sponsor.
- NCT06734858 — Pivotal Trial of SAT-014 for Trauma and Stressor-Related Disorder Symptoms · NA · completed
- NCT06729723 — Exploratory Study on the Effect of SAT-001 on Choroidal Thickness in Pediatric Myopia Patients · NA · completed
- NCT06439407 — Clinical Trial to Preliminarily Assess the Safety and Feasibility of SAT-014, a Software for Alleviating Symptoms of Tra · NA · completed
- NCT06344572 — Pivotal Study of SAT-001 in Treatment of Pediatric Patient With Myopia · NA · recruiting
- NCT06476197 — Exploratory Trial of SAT-003 in Cancer Cachexia Patients With Discontinued Chemotherapy · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06742268 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by S-Alpha Therapeutics, Inc.
- Last refreshed: 9 January 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06742268.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing